Comment
doi: 10.1007/s11912-003-0094-7.
Pegylated interferon alfa-2b as treatment of patients with solid tumors
- PMID: 12583824
- DOI: 10.1007/s11912-003-0094-7
Item in Clipboard
Comment
Pegylated interferon alfa-2b as treatment of patients with solid tumors
Curr Oncol Rep.
2003 Mar.
No abstract available
Comment on
-
Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study.J Clin Oncol. 2002 Sep 15;20(18):3841-9. doi: 10.1200/JCO.2002.02.051. J Clin Oncol. 2002. PMID: 12228203 Clinical Trial.
Similar articles
-
Pegylated interferon alfa-2b treatment for patients with solid tumors: a phase I/II study.J Clin Oncol. 2002 Sep 15;20(18):3841-9. doi: 10.1200/JCO.2002.02.051. J Clin Oncol. 2002. PMID: 12228203 Clinical Trial.
-
Efficacy and safety of pegylated interferon alfa-2b and ribavirin combination therapy versus pegylated interferon monotherapy in hemodialysis patients: a comparison of 2 sequentially treated cohorts.Am J Kidney Dis. 2013 Oct;62(4):789-95. doi: 10.1053/j.ajkd.2013.03.037. Epub 2013 Jun 5. Am J Kidney Dis. 2013. PMID: 23746377 Clinical Trial.
-
Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C.Clin Pharmacol Ther. 2001 Jun;69(6):407-21. doi: 10.1067/mcp.2001.115872. Clin Pharmacol Ther. 2001. PMID: 11406738 Clinical Trial.
-
Pegylated interferons for the treatment of chronic hepatitis C infection.Clin Ther. 2002 Sep;24(9):1363-83. doi: 10.1016/s0149-2918(02)80042-x. Clin Ther. 2002. PMID: 12380630 Review.
-
Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C.Rev Gastroenterol Disord. 2003 Spring;3(2):93-109. Rev Gastroenterol Disord. 2003. PMID: 12776006 Review.